8‐methoxypsoralen plus UVA (PUVA) therapy normalizes signalling of phosphorylated component of mTOR pathway in psoriatic skin of K5.hTGFβ1 transgenic mice

This publication has 9 references indexed in Scilit:

• Balance of Treg versus T‐effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol–betamethasone dipropionate ointment
  Experimental Dermatology, 2014
• Cellular sources of IL‐17 in psoriasis: a paradigm shift?
  Experimental Dermatology, 2014
• Phosphoinositide-3 Kinase/Protein Kinase-B/Mammalian Target of Rapamycin Pathway in Psoriasis Pathogenesis. A Potential Therapeutic Target?
  Acta Dermato-Venereologica, 2014
• Topical application of rapamycin ointment ameliorates Dermatophagoides farina body extract‐induced atopic dermatitis in NC/Nga mice
  Experimental Dermatology, 2014
• Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skin
  British Journal of Dermatology, 2013
• Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry
  British Journal of Dermatology, 2011
• Platelet-Activating Factor Blockade Inhibits the T-Helper Type 17 Cell Pathway and Suppresses Psoriasis-Like Skin Disease in K5.hTGF-β1 Transgenic Mice
  The American Journal of Pathology, 2011
• 8-Methoxypsoralen Plus Ultraviolet A Therapy Acts via Inhibition of the IL-23/Th17 Axis and Induction of Foxp3+ Regulatory T Cells Involving CTLA4 Signaling in a Psoriasis-Like Skin Disorder
  The Journal of Immunology, 2010
• Psoriasis
  New England Journal of Medicine, 2009